Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.

De Stefano N, Vermersch P, Wiendl H, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, Prat A, Leocani L, Schmierer K, Sellebjerg F, Nolting A, Petit C, Guala D, Sponton L, Gardner L, Hodgkinson S

Open source

DOI: 10.1177/13524585261467624
Published: 2026 Aug 4
Container: Multiple sclerosis (Houndmills, Basingstoke, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/13524585261467624,
  title = {Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.},
  author = {De Stefano N and Vermersch P and Wiendl H and Barkhof F and Montalban X and Achiron A and Derfuss T and Chan A and Prat A and Leocani L and Schmierer K and Sellebjerg F and Nolting A and Petit C and Guala D and Sponton L and Gardner L and Hodgkinson S},
  year = {2026},
  journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
  doi = {10.1177/13524585261467624},
  url = {https://doi.org/10.1177/13524585261467624}
}

RIS

TY  - JOUR
TI  - Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.
AU  - De Stefano N
AU  - Vermersch P
AU  - Wiendl H
AU  - Barkhof F
AU  - Montalban X
AU  - Achiron A
AU  - Derfuss T
AU  - Chan A
AU  - Prat A
AU  - Leocani L
AU  - Schmierer K
AU  - Sellebjerg F
AU  - Nolting A
AU  - Petit C
AU  - Guala D
AU  - Sponton L
AU  - Gardner L
AU  - Hodgkinson S
PY  - 2026
JO  - Multiple sclerosis (Houndmills, Basingstoke, England)
DO  - 10.1177/13524585261467624
UR  - https://doi.org/10.1177/13524585261467624
ER  -

APA

N, D. S., P, V., H, W., F, B., X, M., A, A., T, D., A, C., A, P., L, L., K, S., F, S., A, N., C, P., D, G., L, S., L, G., & S, H. (2026). Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.. Multiple sclerosis (Houndmills, Basingstoke, England). https://doi.org/10.1177/13524585261467624

Source records

pubmed · retrieved 2026-09-25T20:46:55.732Z